122 related articles for article (PubMed ID: 7248523)
21. 5'-deoxypyridoxal as a potential anti-sickling agent.
Benesch R; Benesch RE; Edalji R; Suzuki T
Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1721-3. PubMed ID: 266212
[TBL] [Abstract][Full Text] [Related]
22. Physiologic and rheologic effects of the antisickling agent ethacrynic acid and its N-butylated derivative on normal and sickle erythrocytes.
Orringer EP; Blythe DS; Whitney JA; Brockenbrough S; Abraham DJ
Am J Hematol; 1992 Jan; 39(1):39-44. PubMed ID: 1536139
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and testing of potential antisickling agents. 10. (2,2-Dimethylchroman-6-yl)alkanoic acids.
Fatope MO; Abraham DJ
J Med Chem; 1987 Nov; 30(11):1973-7. PubMed ID: 3669005
[TBL] [Abstract][Full Text] [Related]
24. Oxygen equilibria of hemoglobin A and hemoglobin S valency hybrids.
Murari J
Arch Biochem Biophys; 1977 May; 181(1):1-4. PubMed ID: 18100
[No Abstract] [Full Text] [Related]
25. Extracorporeal treatment of erythrocytes in sickle cell anemia: hemoglobin carbamylation.
Diederich D; Curran M; Odenbaugh A; Diederich A; Core E
Tex Rep Biol Med; 1980-1981; 40():313-22. PubMed ID: 7323976
[No Abstract] [Full Text] [Related]
26. Metabolic effects of antisickling amounts of nitrogen and nor-nitrogen mustard on rabbit and human erythrocytes.
Roth EF; Nagel RL; Neuman G; Vanderhoff G; Kaplan BH; Jaffé ER
Blood; 1975 Jun; 45(6):779-88. PubMed ID: 1125427
[TBL] [Abstract][Full Text] [Related]
27. Sickle hemoglobin aggregation: a new class of inhibitors.
Votano JR; Gorecki M; Rich A
Science; 1977 Jun; 196(4295):1216-9. PubMed ID: 870976
[TBL] [Abstract][Full Text] [Related]
28. Identification of a novel class of covalent modifiers of hemoglobin as potential antisickling agents.
Omar AM; Mahran MA; Ghatge MS; Chowdhury N; Bamane FH; El-Araby ME; Abdulmalik O; Safo MK
Org Biomol Chem; 2015 Jun; 13(22):6353-70. PubMed ID: 25974708
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and testing of potential antisickling agents. 6. Rheologic studies with active phenoxy and benzyloxy acids.
Patwa DC; Abraham DJ; Hung TC
Blood Cells; 1987; 12(3):589-601. PubMed ID: 3651614
[TBL] [Abstract][Full Text] [Related]
30. Covalent inhibitors of the gelation of sickle cell hemoglobin and their effects on function.
Manning JM
Adv Enzymol Relat Areas Mol Biol; 1991; 64():55-91. PubMed ID: 2053469
[No Abstract] [Full Text] [Related]
31. Ligand kinetics of hemoglobin S containing erythrocytes.
Harrington JP; Elbaum D; Bookchin RM; Wittenberg JB; Nagel RL
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):203-6. PubMed ID: 264675
[TBL] [Abstract][Full Text] [Related]
32. Time resolved absorption study of the reaction of hydroxyurea with sickle cell hemoglobin.
Kim-Shapiro DB; King SB; Bonifant CL; Kolibash CP; Ballas SK
Biochim Biophys Acta; 1998 Mar; 1380(1):64-74. PubMed ID: 9545536
[TBL] [Abstract][Full Text] [Related]
33. Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.
Okam MM; Ebert BL
Expert Rev Hematol; 2012 Jun; 5(3):303-11. PubMed ID: 22780210
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, DNA sequence preferential alkylation and biological evaluation of N-mustard derivatives of distamycin and netropsin analogues.
Xie G; Gupta R; Lown JW
Anticancer Drug Des; 1995 Jul; 10(5):389-409. PubMed ID: 7639929
[TBL] [Abstract][Full Text] [Related]
35. Covalent binding of glutathione to hemoglobin. I. Inhibition of hemoglobin S polymerization.
Garel MC; Domenget C; Caburi-Martin J; Prehu C; Galacteros F; Beuzard Y
J Biol Chem; 1986 Nov; 261(31):14704-9. PubMed ID: 3771547
[TBL] [Abstract][Full Text] [Related]
36. Alternative aspirins as antisickling agents: acetyl-3,5-dibromosalicylic acid.
Walder JA; Zaugg RH; Iwaoka RS; Watkin WG; Klotz IM
Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5499-503. PubMed ID: 271972
[TBL] [Abstract][Full Text] [Related]
37. In vitro effects of NIPRISAN (Nix-0699): a naturally occurring, potent antisickling agent.
Iyamu EW; Turner EA; Asakura T
Br J Haematol; 2002 Jul; 118(1):337-43. PubMed ID: 12100171
[TBL] [Abstract][Full Text] [Related]
38. Sickling-suppressive effects of chrysin may be associated with sequestration of deoxy-haemoglobin, 2,3-bisphosphoglycerate mutase, alteration of redox homeostasis and functional chemistry of sickle erythrocytes.
Muhammad A; Waziri AD; Forcados GE; Sanusi B; Sani H; Malami I; Abubakar IB; Muhammad A; Muhammad RA; Mohammed HA
Hum Exp Toxicol; 2020 Apr; 39(4):537-546. PubMed ID: 31876182
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and testing of potential antisickling agents. 3. Ethacrynic acid.
Kennedy PE; Williams FL; Abraham DJ
J Med Chem; 1984 Feb; 27(2):103-5. PubMed ID: 6694161
[No Abstract] [Full Text] [Related]
40. Targeting HbS Polymerization.
Ferrone FA
Semin Hematol; 2018 Apr; 55(2):53-59. PubMed ID: 30616807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
